Appeal No. 1997-2195
Application 08/102,752
rejected under 35 U.S.C. § 103 as follows: claim 1 over Lachhein;
claims 1, 6 and 7 over Hamprecht ‘927 in view of Lachhein;
claims
1, 6 and 7 over Meyer; and claims 2-5 over Hamprecht ‘927.2
OPINION
Appellant does not challenge the obviousness-type double
patenting rejections (brief, page 5). We therefore summarily
affirm these rejections.
As for the rejections under 35 U.S.C. § 103, we have
carefully considered all of the arguments advanced by appellant
and the examiner and agree with appellant that these rejections
are not well founded. Accordingly, we reverse the rejections
under 35 U.S.C. § 103.
Rejection of claim 1 over Lacchein
Lacchein discloses pyrimidines which are useful as
intermediates in the production of sulfonylureas which have a
herbicidal effect (page 3). The pyrimidines have hydrogen at the
2A rejection of claim 1 under 35 U.S.C. § 102(b) over
Lachhein is withdrawn in the answer (page 2).
3
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: November 3, 2007